Here, we conducted a comprehensive bioinformatic and clinical analysis on the characteristics of pan-cancer <i>ALK</i> mutation and its association with tumor immunity and the efficacy of immune checkpoint blockade. This evidence concerns the gene ALK and neoplasm.